Karen Kozarsky

Karen Kozarsky

Company: Swan Bio Therapeutics

Job title: Founder Chief Scientific Officer


Strategy for selection of clinical doses for SBT101, a gene therapy for the treatment of adrenomyeloneuropathy (AMN) 2:30 pm

Selection of AAV vector and delivery for AMN How target engagement and efficacy studies supported starting dose Safety studies further supported dose selectionRead more

day: Day One: Track B PM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.